Nonetheless, treatment decisions should be guided by the presence of chronic kidney disease-mineral and bone disorder (CKD-MBD), as indicated by abnormal calcium, phosphate, PTH, alkaline phosphatase, or calcifediol levels. This evidence concerns the gene PTH and chronic kidney disease.